Management of Isolated Hyperbilirubinemia with Normal Liver Function Tests

Initial Diagnostic Approach

The American Gastroenterological Association recommends determining whether the hyperbilirubinemia is conjugated or unconjugated by ordering fractionated bilirubin tests in patients with isolated hyperbilirubinemia and normal liver function tests 1, 2
If unconjugated bilirubin comprises the majority (>70-80%) of total bilirubin, in the absence of hemolysis, the European Association for the Study of the Liver suggests that Gilbert's syndrome is the most likely diagnosis 2, 3
The presence of conjugated hyperbilirubinemia (>20-30% of total bilirubin is conjugated) warrants further evaluation for liver disease or biliary obstruction, according to the American Association for the Study of Liver Diseases 2, 4

The European Association for the Study of the Liver recommends evaluating for Gilbert's syndrome, which is the most common cause of isolated unconjugated hyperbilirubinemia 3
A hemolysis workup (complete blood count, reticulocyte count, haptoglobin, LDH) is suggested by the American Gastroenterological Association to rule out hemolysis in patients with unconjugated hyperbilirubinemia 1, 5
The American Association for the Study of Liver Diseases advises reviewing medications that may cause hyperbilirubinemia in patients with unconjugated hyperbilirubinemia 5
Genetic testing for UDP-glucuronosyltransferase mutations can confirm Gilbert's syndrome if diagnosis is uncertain, according to the American Association for the Study of Liver Diseases 4

The American Gastroenterological Association recommends performing abdominal ultrasound to exclude biliary obstruction in patients with conjugated hyperbilirubinemia 1, 5
Additional imaging (CT or MRI) may be considered if ultrasound is inconclusive, according to the American Gastroenterological Association 1
The European Association for the Study of the Liver suggests evaluating for drug-induced liver injury by reviewing medication history in patients with conjugated hyperbilirubinemia 6
Viral hepatitis serologies, autoimmune markers, and other causes of liver disease should be considered in patients with conjugated hyperbilirubinemia, according to the European Association for the Study of the Liver 7

Gilbert's syndrome typically presents with mild unconjugated hyperbilirubinemia (rarely >4-5 mg/dL) and requires no treatment, according to the American Association for the Study of Liver Diseases 4
Persistent isolated elevations of direct bilirubin in patients with otherwise normal liver tests should be closely monitored, as this may indicate early liver disease, suggests the American Association for the Study of Liver Diseases 4

For Gilbert's syndrome, the European Association for the Study of the Liver recommends providing reassurance, as no specific treatment is needed 3
For drug-induced hyperbilirubinemia, the American Association for the Study of Liver Diseases suggests considering medication discontinuation if appropriate 6
For biliary obstruction, the American Gastroenterological Association recommends appropriate surgical or endoscopic intervention may be required 1

If unconjugated hyperbilirubinemia consistent with Gilbert's syndrome is diagnosed, the European Association for the Study of the Liver suggests that no further follow-up is typically needed 3
For unexplained conjugated hyperbilirubinemia with normal LFTs, the European Association for the Study of the Liver recommends considering follow-up in 2-4 weeks with repeat testing 2
If initial workup is inconclusive and hyperbilirubinemia persists, the European Association for the Study of the Liver suggests considering liver biopsy to exclude parenchymal liver disease 7